A Case Report on Prolonged Response with Trastuzumab Emtansine (T-DM1) in Recurrent Advance Breast Cancer Setting. (2023). Journal of Cancer Research Updates, 12, 49-53. https://doi.org/10.30683/1929-2279.2023.12.9